The Journal of the Association of Physicians of India
-
J Assoc Physicians India · May 2014
Randomized Controlled TrialA Clinical Trial of Nitrosense patch for the treatment of patients with painful diabetic neuropathy.
Impaired nitric oxide synthesis has been implicated as one of the underlying causes of diabetic painful neuropathy (DPN). Hence, effects of a cutaneous, nitric oxide releasing patch (NitroSense Derma Protect) were evaluated in subjects with DPN. ⋯ Present results highlight utility of NitroSense Derma Protect as controllable nitric oxide source for patients with DPN.